A new strategy to cure disease in a single day, and forever: epigenetic silencing
By Manuel Ansede,
El País
| 03. 01. 2024
A team of Italian researchers has reached a major scientific milestone, heralding a revolution in the field of medicine. The scientists have succeeded in silencing a gene associated with high cholesterol levels, without the need to modify DNA. In the experiment, which was conducted on mice, the effects of the gene silencing persisted for the entire year that the experiment lasted — a period equivalent to half an average human life. These results suggest that it may be possible to solve chronic health problems, permanently, and in a single day of treatment. The study was published this Wednesday in the journal Nature, a leading reference in the world of science.
DNA is like a book, with some 3 billion chemical letters, that provides instructions for the functioning of every cell. This immense text is divided into pages — the genes — which contain specific recipes for making the proteins necessary for life: the collagen in cartilage, the hemoglobin in blood, the antibodies that fight pathogens. One of these genes, PCSK9, contains guidelines for producing a protein associated with...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...